GSK In China: A Game Changer for Compliance

more+
less-

The allegations of bribery and corruption by the UK company GlaxoSmithKline are a true game changer for the compliance world. This is the first time that the Chinese have enforced their domestic anti-corruption laws against western corporations doing business in China. It makes clear that doing business the 'old fashioned way' in China through bribery and corruption will no longer be tolerated.

LOADING PDF: If there are any problems, click here to download the file.

Topics:  Bribery, China, Compliance, Corruption, FCPA, Foreign Official, GlaxoSmithKline

Published In: General Business Updates, Finance & Banking Updates, International Trade Updates, Mergers & Acquisitions Updates, Securities Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Thomas Fox | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »